MYC is also a known BCR binding partner [27] and higher BCR levels can decrease MYC protein levels, thus suggesting that BCR monoallelic disruption through BCR/ABL1 translocation may contribute to MYC protein stability in CML. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.